553 studies found for:    "Hypertension, Pulmonary"
Show Display Options
Rank Status Study
21 Recruiting EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat(BAY63-2521)
22 Terminated Safety of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Terbogrel
23 Completed Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Terbogrel low dose;   Drug: Terbogrel high dose;   Drug: Placebo
24 Recruiting Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (ADEMPAS, BAY63-2521)
25 Completed Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
26 Terminated Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Conditions: Heart Diseases;   Hypertension, Pulmonary
Interventions: Drug: tezosentan;   Drug: placebo
27 Unknown  The Role of Endothelin in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: BQ-123
28 Recruiting Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory Therapy
Conditions: Pulmonary Hypertension;   Chronic Thromboembolic Pulmonary Hypertension
Interventions: Behavioral: exercise and respiratory therapy;   Other: sedentary control group
29 Recruiting Zürich Pulmonary Hypertension Outcome Assessment Cohort
Condition: Pulmonary Hypertension Outcome Assessment
Intervention: Other: PH target therapy according to physician
30 Recruiting A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
31 Unknown  Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
Conditions: Sarcoidosis;   Pulmonary Hypertension
Intervention: Drug: Ambrisentan
32 Not yet recruiting A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries
Condition: Hypertension, Pulmonary
Intervention: Other: Standard of care
33 Completed Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: escitalopram
34 Completed Pulmonary Hypertension, Hypoxia and Sickle Cell Disease
Conditions: Chuvash Polycythemia;   Cerebrovascular Disease;   Pulmonary Hypertension;   Sickle Cell Anemia
Intervention:
35 Recruiting Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
Conditions: Pulmonary Hypertension;   COPD
Intervention: Drug: Inhaled Treprostinil Therapy
36 Terminated Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
Condition: Pulmonary Hypertension
Intervention: Drug: Inhaled Iloprost
37 Terminated
Has Results
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Hypertension
Intervention: Drug: Treprostinil sodium for inhalation
38 Completed
Has Results
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Pulmonary Hypertension
Intervention: Drug: bosentan
39 Terminated Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Condition: Persistent Pulmonary Hypertension of Newborn (PPHN)
Intervention: Drug: milrinone lactate
40 Unknown  Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)
Condition: Pulmonary Hypertension
Interventions: Drug: iloprost nebuliser solution;   Drug: distilled water

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years